{
  "trial_id": "NCT02645786",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "thyroid cancer group",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "age less than 45 years old when receiving total or near-total thyroidectomy",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "serum level of TSH<0.1 mU/L in the intermediate -risk or TSH<0.3 mU/L in the low recurrence-risk group over 2 years before study entry",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "receiving TSH suppressive therapy for 5 to 9 years with fixed dose of LT4 more than 2 years before study entry",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "no history of structural heart disease, arrhythmia, or cardiac symptoms (palpitation, exertional dyspnea and chest discomfort) during therapy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "control group",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "the subject matched to a patient by age (\u00b12 years), sex, and body mass index (BMI) (\u00b12 kg/m2)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "within the reference range of serum TSH (0.3-4.6 mU/L)",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "no history of structural heart disease, arrhythmia, or cardiac symptoms",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "no history of comorbid diseases which affect thyroxine metabolism and cardiac structure, including hepatic or renal disease, anemia, and hypertension",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "who had arrhythmia in electrography or history of cardiac disease",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has Hashimoto's thyroiditis, high TSH level (13 mU/L), and low free T4 level (0.2 ng/dl). She was diagnosed with Hashimoto's thyroiditis and her symptoms improved significantly after starting Levothyroxine per day.",
  "_meta": {
    "topic_id": "30",
    "trial_id": "NCT02645786",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}